Clinical Trials Browser

OTHER × Lomustine × 30 days × Clear all

NCT03970447 2026-04-08

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT05095376 2026-04-03

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

Phase 3 Active not recruiting

Glioblastoma, Gliosarcoma